Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Marbiopharm is a long-standing Russian pharmaceutical manufacturer headquartered in Yoshkar-Ola, Mari El Republic. Established in 1942 during World War II as a vitamin factory, the company has evolved into a full-cycle pharmaceutical enterprise producing active pharmaceutical ingredients (APIs), finished dosage forms, and dietary supplements. Its product portfolio features over 70 items, including a wide range of vitamin-mineral complexes and generic medications for cardiology, gastroenterology, and infectious diseases. The company operates according to international GMP standards and is a significant supplier to both the Russian domestic market and various CIS countries. Marbiopharm is part of the Biotek group of companies, a major player in the Russian healthcare distribution and manufacturing sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Marbiopharm.